Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Derek Raghavan

Showing results (91-100 of 130) with videos related to

Pageof 13
Sort By:
Cancer|June 22, 2010
Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapyBrian R Lane, Armine K Smith, Benjamin T Larson, et al.
Cancer|May 12, 2006
Southwest Oncology Group phase II study of arsenic trioxide in patients with refractory germ cell malignanciesTomasz M Beer, Catherine M Tangen, Craig R Nichols, et al.
Urology|January 31, 2004
Phase I and clinical pharmacology of a type I and II, 5-alpha-reductase inhibitor (LY320236) in prostate cancer: elevation of estradiol as possible mechanism of actionMario A Eisenberger, Menachem Laufer, Nicholas J Vogelzang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 27, 2023
Radical Cystectomy in the Treatment of Invasive Bladder Cancer: Long-Term Results in 1,054 PatientsJohn P Stein, Gary Lieskovsky, Richard Cote, et al.
Cancer|August 28, 2003
Natural history of surgically treated bladder carcinoma with extravesical tumor extensionMarcus L Quek, John P Stein, Peter E Clark, et al.
The Oncologist|June 6, 2018
Comparative Molecular Analyses of Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, and Gastric AdenocarcinomaMohamed E Salem, Alberto Puccini, Joanne Xiu, et al.
The Oncologist|July 21, 2021
Impact of Sociodemographic Disparities and Insurance Status on Survival of Patients with Early-Onset Colorectal CancerMohamed E Salem, Alberto Puccini, Sally J Trufan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 22, 2006
Absolute prostate-specific antigen value after androgen deprivation is a strong independent predictor of survival in new metastatic prostate cancer: data from Southwest Oncology Group Trial 9346 (INT-0162)Maha Hussain, Catherine M Tangen, Celestia Higano, et al.
Urologic Oncology|January 21, 2019
Discordance of high PD-L1 expression in primary and metastatic urothelial carcinoma lesionsEarle F Burgess, Chad Livasy, Aaron Hartman, et al.
Radiation Oncology (London, England)|February 5, 2021
Implementation, adherence, and results of systematic SARS-CoV-2 testing for asymptomatic patients treated at a tertiary care regional radiation oncology networkRoshan S Prabhu, Reshika Dhakal, Amy S Hicks, et al.
Pageof 13

Showing results (91-100 of 130) with videos related to

Sort By:
Pageof 13
Cancer|June 22, 2010
Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapyBrian R Lane, Armine K Smith, Benjamin T Larson, et al.
Cancer|May 12, 2006
Southwest Oncology Group phase II study of arsenic trioxide in patients with refractory germ cell malignanciesTomasz M Beer, Catherine M Tangen, Craig R Nichols, et al.
Urology|January 31, 2004
Phase I and clinical pharmacology of a type I and II, 5-alpha-reductase inhibitor (LY320236) in prostate cancer: elevation of estradiol as possible mechanism of actionMario A Eisenberger, Menachem Laufer, Nicholas J Vogelzang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 27, 2023
Radical Cystectomy in the Treatment of Invasive Bladder Cancer: Long-Term Results in 1,054 PatientsJohn P Stein, Gary Lieskovsky, Richard Cote, et al.
Cancer|August 28, 2003
Natural history of surgically treated bladder carcinoma with extravesical tumor extensionMarcus L Quek, John P Stein, Peter E Clark, et al.
The Oncologist|June 6, 2018
Comparative Molecular Analyses of Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, and Gastric AdenocarcinomaMohamed E Salem, Alberto Puccini, Joanne Xiu, et al.
The Oncologist|July 21, 2021
Impact of Sociodemographic Disparities and Insurance Status on Survival of Patients with Early-Onset Colorectal CancerMohamed E Salem, Alberto Puccini, Sally J Trufan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 22, 2006
Absolute prostate-specific antigen value after androgen deprivation is a strong independent predictor of survival in new metastatic prostate cancer: data from Southwest Oncology Group Trial 9346 (INT-0162)Maha Hussain, Catherine M Tangen, Celestia Higano, et al.
Urologic Oncology|January 21, 2019
Discordance of high PD-L1 expression in primary and metastatic urothelial carcinoma lesionsEarle F Burgess, Chad Livasy, Aaron Hartman, et al.
Radiation Oncology (London, England)|February 5, 2021
Implementation, adherence, and results of systematic SARS-CoV-2 testing for asymptomatic patients treated at a tertiary care regional radiation oncology networkRoshan S Prabhu, Reshika Dhakal, Amy S Hicks, et al.
Pageof 13